These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 27002129)

  • 1. AB5 Preassembly Is Not Required for Shiga Toxin Activity.
    Pellino CA; Karve SS; Pradhan S; Weiss AA
    J Bacteriol; 2016 Jun; 198(11):1621-1630. PubMed ID: 27002129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The A1 Subunit of Shiga Toxin 2 Has Higher Affinity for Ribosomes and Higher Catalytic Activity than the A1 Subunit of Shiga Toxin 1.
    Basu D; Li XP; Kahn JN; May KL; Kahn PC; Tumer NE
    Infect Immun; 2016 Jan; 84(1):149-61. PubMed ID: 26483409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Switching Shiga Toxin (Stx) Type from Stx2d to Stx2a but Not Stx2c Alters Virulence of Stx-Producing
    McNichol BA; Bova RA; Torres K; Preston LN; Melton-Celsa AR
    Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33467588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and characterization of recombinant antibody fragments that recognize and neutralize in vitro Stx2 toxin from Shiga toxin-producing Escherichia coli.
    Luz D; Chen G; Maranhão AQ; Rocha LB; Sidhu S; Piazza RM
    PLoS One; 2015; 10(3):e0120481. PubMed ID: 25790467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do the A subunits contribute to the differences in the toxicity of Shiga toxin 1 and Shiga toxin 2?
    Basu D; Tumer NE
    Toxins (Basel); 2015 Apr; 7(5):1467-85. PubMed ID: 25938272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons of native Shiga toxins (Stxs) type 1 and 2 with chimeric toxins indicate that the source of the binding subunit dictates degree of toxicity.
    Russo LM; Melton-Celsa AR; Smith MJ; O'Brien AD
    PLoS One; 2014; 9(3):e93463. PubMed ID: 24671194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shiga Toxin Type 1a (Stx1a) Reduces the Toxicity of the More Potent Stx2a
    Petro CD; Trojnar E; Sinclair J; Liu ZM; Smith M; O'Brien AD; Melton-Celsa A
    Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30670557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced Toxicity of Shiga Toxin (Stx) Type 2c in Mice Compared to Stx2d Is Associated with Instability of Stx2c Holotoxin.
    Bunger JC; Melton-Celsa AR; Maynard EL; O'Brien AD
    Toxins (Basel); 2015 Jun; 7(6):2306-20. PubMed ID: 26110507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bimodal Response to Shiga Toxin 2 Subtypes Results from Relatively Weak Binding to the Target Cell.
    Cherubin P; Fidler D; Quiñones B; Teter K
    Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31527121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining Mass Spectrometry, Surface Acoustic Wave Interaction Analysis, and Cell Viability Assays for Characterization of Shiga Toxin Subtypes of Pathogenic Escherichia coli Bacteria.
    Steil D; Pohlentz G; Legros N; Mormann M; Mellmann A; Karch H; Müthing J
    Anal Chem; 2018 Aug; 90(15):8989-8997. PubMed ID: 29939014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Antibodies Against Shiga Toxins: Trends and Perspectives.
    Henrique IM; Sacerdoti F; Ferreira RL; Henrique C; Amaral MM; Piazza RMF; Luz D
    Front Cell Infect Microbiol; 2022; 12():825856. PubMed ID: 35223548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human intestinal tissue and cultured colonic cells contain globotriaosylceramide synthase mRNA and the alternate Shiga toxin receptor globotetraosylceramide.
    Zumbrun SD; Hanson L; Sinclair JF; Freedy J; Melton-Celsa AR; Rodriguez-Canales J; Hanson JC; O'Brien AD
    Infect Immun; 2010 Nov; 78(11):4488-99. PubMed ID: 20732996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycolipid binding preferences of Shiga toxin variants.
    Karve SS; Weiss AA
    PLoS One; 2014; 9(7):e101173. PubMed ID: 24983355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Escherichia coli Shiga toxin.
    Nakao H; Takeda T
    J Nat Toxins; 2000 Aug; 9(3):299-313. PubMed ID: 10994531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of probiotics and organic acids on Shiga-toxin 2 gene expression in enterohemorrhagic Escherichia coli O157:H7.
    Carey CM; Kostrzynska M; Ojha S; Thompson S
    J Microbiol Methods; 2008 May; 73(2):125-32. PubMed ID: 18328583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of antibiotics on cellular stress generated in Shiga toxin-producing Escherichia coli O157:H7 and non-O157 biofilms.
    Angel Villegas N; Baronetti J; Albesa I; Etcheverría A; Becerra MC; Padola NL; Paraje MG
    Toxicol In Vitro; 2015 Oct; 29(7):1692-700. PubMed ID: 26130220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Shiga toxin 2 (Stx2) in highly virulent Stx-producing Escherichia coli (STEC) carrying different anti-terminator (q) genes.
    Olavesen KK; Lindstedt BA; Løbersli I; Brandal LT
    Microb Pathog; 2016 Aug; 97():1-8. PubMed ID: 27208749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome.
    Orth D; Grif K; Khan AB; Naim A; Dierich MP; Würzner R
    Diagn Microbiol Infect Dis; 2007 Nov; 59(3):235-42. PubMed ID: 17931818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Conserved Structural Motif Mediates Retrograde Trafficking of Shiga Toxin Types 1 and 2.
    Selyunin AS; Mukhopadhyay S
    Traffic; 2015 Dec; 16(12):1270-87. PubMed ID: 26420131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptides derived from phage display libraries as potential neutralizers of Shiga toxin-induced cytotoxicity in vitro and in vivo.
    Bernedo-Navarro RA; Miyachiro MM; da Silva MJ; Reis CF; Conceição RA; Gatti MS; Yano T
    J Appl Microbiol; 2014 May; 116(5):1322-33. PubMed ID: 24447276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.